39 related articles for article (PubMed ID: 38472944)
1. Compromised T Cell Immunity Links Increased Cutaneous Papillomavirus Activity to Squamous Cell Carcinoma Risk.
Johnson LH; Son HG; Ha DT; Strickley JD; Joh J; Demehri S
JID Innov; 2023 Mar; 3(2):100163. PubMed ID: 36714811
[TBL] [Abstract][Full Text] [Related]
2. Association Between β-Genus Human Papillomavirus and Cutaneous Squamous Cell Carcinoma in Immunocompetent Individuals-A Meta-analysis.
Chahoud J; Semaan A; Chen Y; Cao M; Rieber AG; Rady P; Tyring SK
JAMA Dermatol; 2016 Dec; 152(12):1354-1364. PubMed ID: 26720285
[TBL] [Abstract][Full Text] [Related]
3. Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition Therapy.
Cohen DN; Lawson SK; Shaver AC; Du L; Nguyen HP; He Q; Johnson DB; Lumbang WA; Moody BR; Prescott JL; Chandra PK; Boyd AS; Zwerner JP; Robbins JB; Tyring SK; Rady PL; Chappell JD; Shyr Y; Infante JR; Sosman JA
Clin Cancer Res; 2015 Jun; 21(11):2624-34. PubMed ID: 25724524
[TBL] [Abstract][Full Text] [Related]
4. WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma.
Zimmerli D; Cecconi V; Valenta T; Hausmann G; Cantù C; Restivo G; Hafner J; Basler K; van den Broek M
Oncogene; 2018 Jul; 37(27):3753-3762. PubMed ID: 29662191
[TBL] [Abstract][Full Text] [Related]
5. Concomitant seropositivity for HPV 16 and cutaneous HPV types increases the risk of recurrent squamous cell carcinoma of the skin.
Paradisi A; Waterboer T; Ricci F; Sampogna F; Pawlita M; Abeni D
Eur J Dermatol; 2020 Oct; 30(5):493-498. PubMed ID: 33052107
[TBL] [Abstract][Full Text] [Related]
6. T Cell Immunity in Human Papillomavirus-Related Cutaneous Squamous Cell Carcinoma-A Systematic Review.
Tay SH; Oh CC
Diagnostics (Basel); 2024 Feb; 14(5):. PubMed ID: 38472944
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system.
Yesantharao P; Wang W; Ioannidis NM; Demehri S; Whittemore AS; Asgari MM
Hum Immunol; 2017 Apr; 78(4):327-335. PubMed ID: 28185865
[TBL] [Abstract][Full Text] [Related]
8. Beta Human Papillomavirus and Associated Diseases.
Sichero L; Rollison DE; Amorrortu RP; Tommasino M
Acta Cytol; 2019; 63(2):100-108. PubMed ID: 30673666
[TBL] [Abstract][Full Text] [Related]
9. The Role of the Immune System in Cutaneous Squamous Cell Carcinoma.
Bottomley MJ; Thomson J; Harwood C; Leigh I
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022866
[TBL] [Abstract][Full Text] [Related]
10. Sun protection for preventing basal cell and squamous cell skin cancers.
Sánchez G; Nova J; Rodriguez-Hernandez AE; Medina RD; Solorzano-Restrepo C; Gonzalez J; Olmos M; Godfrey K; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011161. PubMed ID: 27455163
[TBL] [Abstract][Full Text] [Related]
11. Human Immunodeficiency Virus Infection Promotes Human Papillomavirus-Mediated Anal Squamous Carcinogenesis: An Immunologic and Pathobiologic Review.
Bushara O; Krogh K; Weinberg SE; Finkelman BS; Sun L; Liao J; Yang GY
Pathobiology; 2022; 89(1):1-12. PubMed ID: 34535611
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Squamous Cell Carcinoma: The Frontier of Cancer Immunoprevention.
Chang MS; Azin M; Demehri S
Annu Rev Pathol; 2022 Jan; 17():101-119. PubMed ID: 35073167
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
